Aberdeen Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $31.1M | Buy |
114,574
+7,879
| +7% | +$2.14M | 0.1% | 187 |
|
|
2017
Q1 | $29.2M | Buy |
106,695
+12,753
| +14% | +$3.49M | 0.1% | 188 |
|
|
2016
Q4 | $26.6M | Sell |
93,942
-4,313
| -4% | -$1.22M | 0.1% | 185 |
|
|
2016
Q3 | $30.8M | Sell |
98,255
-2,836
| -3% | -$888K | 0.11% | 150 |
|
|
2016
Q2 | $24.4M | Sell |
101,091
-2,700
| -3% | -$653K | 0.09% | 172 |
|
|
2016
Q1 | $27M | Sell |
103,791
-13,095
| -11% | -$3.41M | 0.1% | 145 |
|
|
2015
Q4 | $32.4M | Buy |
116,886
+7,820
| +7% | +$2.16M | 0.11% | 127 |
|
|
2015
Q3 | $31.8M | Buy |
109,066
+5,884
| +6% | +$1.72M | 0.11% | 114 |
|
|
2015
Q2 | $41.7M | Buy |
103,182
+1,773
| +2% | +$716K | 0.12% | 97 |
|
|
2015
Q1 | $42.8M | Sell |
101,409
-5,765
| -5% | -$2.43M | 0.12% | 98 |
|
|
2014
Q4 | $36.4M | Sell |
107,174
-13,669
| -11% | -$4.64M | 0.09% | 120 |
|
|
2014
Q3 | $40M | Buy |
120,843
+11,740
| +11% | +$3.88M | 0.09% | 135 |
|
|
2014
Q2 | $34.4M | Buy |
109,103
+84,236
| +339% | +$26.6M | 0.07% | 161 |
|
|
2014
Q1 | $7.6M | Sell |
24,867
-200
| -0.8% | -$61.2K | 0.02% | 144 |
|
|
2013
Q4 | $6.96M | Hold |
25,067
| – | – | 0.02% | 151 |
|
|
2013
Q3 | $6.04M | Sell |
25,067
-2,380
| -9% | -$573K | 0.02% | 152 |
|
|
2013
Q2 | $5.91M | Buy |
+27,447
| New | +$5.91M | 0.02% | 154 |
|